Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Erratum for Rodrigues et al., J Clin Oncol 27 (2) 256-263.

Journal of Clinical Oncology, Vol 27, No 11 (April 10), 2009: pp. 1923
© 2009 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2009.22.9435

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ERRATA

The January 10, 2009, article by Rodrigues et al entitled, "Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation" (J Clin Oncol 27:256–263, 2009) contained errors.

In the Results section, under PFS and OS, the second sentence referred to Figure 2 and Figure 3, whereas it should have been Figure 1A and Figure 1B, as follows:

"Factors associated with PFS were age at least 41 years (54% v 28%; P = .02), presence of chemosensitive disease (49% v 34%; P = .04), histologic subtype (60% in indolent NHL, 75% in mantle cell NHL, 29% in aggressive NHL, and 30% in HL; P = .02; Fig 1A), use of low-dose TBI (59% v 20% in patients not receiving TBI and 33% in those receiving high-dose TBI; P < .0001), use of regimens not incorporating ATG/ALG (56% v 23%; P = .001; Fig 1B), and a TNC dose higher than 2 x 107/kg (49% v 21%; P < .0001)."

The online version has been corrected in departure from the print.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online